RenovoRx, Inc.RNXTEarnings & Financial Report
Nasdaq
RNXT Q3 2025 Key Financial Metrics
Revenue
$266.0K
Gross Profit
$213.0K
Operating Profit
$-3.2M
Net Profit
$-2.9M
Gross Margin
80.1%
Operating Margin
-1203.0%
Net Margin
-1094.7%
YoY Growth
N/A
EPS
$-0.08
Financial Flow
RenovoRx, Inc. Q3 2025 Financial Summary
RenovoRx, Inc. reported revenue of $266.0K for Q3 2025, with a net profit of $-2.9M (-1094.7% margin). Cost of goods sold was $53.0K, operating expenses totaled $3.4M.
Key Financial Metrics
| Total Revenue | $266.0K |
|---|---|
| Net Profit | $-2.9M |
| Gross Margin | 80.1% |
| Operating Margin | -1203.0% |
| Report Period | Q3 2025 |
Income Statement
| Q1 2022 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|
| Revenue | $1000 | $197000 | $422000 | $266000 |
| YoY Growth | 100.4% | N/A | N/A | N/A |
Balance Sheet
| Q1 2022 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|
| Assets | $13.9M | $16.0M | $13.6M | $11.2M |
| Liabilities | $1.4M | $2.9M | $3.0M | $3.1M |
| Equity | $12.5M | $13.2M | $10.6M | $8.1M |
Cash Flow
| Q1 2022 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|
| Operating CF | $-2.1M | $-3.4M | $-2.3M | $-2.3M |